GLP-1 Medical Weight Loss
New Hope, PA | Newtown, PA | Upper Dublin, PA
At La Chelé Medical Aesthetics & Wellness, weight loss is about empowering your body to function at its best.
Our weight loss treatments, including GLP-1 receptor agonist medications like semaglutide and tirzepatide, are part of a medically supervised program designed to support real, sustainable results.
These groundbreaking therapies work by regulating appetite, stabilizing blood sugar, and improving metabolic efficiency, helping you shed stubborn weight and embrace enhanced energy and quality of life.
With nearly two decades of expertise and a physician-led team, we offer a highly personalized approach to weight management. Our GLP-1 program is tailored to your goals, your body, and your long-term health outcomes. Discover a more effective path to weight loss in an environment where luxury meets medical precision.
GLP-1 (glucagon-like peptide 1) receptor agonists are a revolutionary class of medications originally developed to treat diabetes.
GLP-1 medications have gained significant attention for their ability to support weight loss in addition to managing various health conditions, particularly diabetes mellitus. This drug class works by mimicking the effects of a naturally occurring hormone that regulates glucose and controls appetite.
The primary function of GLP-1 receptor agonists is to regulate blood glucose by enhancing insulin secretion in response to food intake. This means that when blood sugar levels rise after eating, GLP-1 receptor activation triggers the release of more insulin to help lower blood sugar.
Besides regulating blood glucose, GLP-1 also slows gastric emptying, leading to a feeling of fullness and reduced appetite to support weight loss. Clinical trials have shown that patients taking GLP-1 agonists experience weight loss and a significant reduction in weight gain, even in those who struggle with weight management due to chronic conditions.
Most GLP-1 medications are administered via a weekly injection. The injection method allows for controlled, steady release of the medication to help manage levels of glucose in the blood and support steady weight loss.
GLP-1 medications, such as semaglutide and tirzepatide, offer a scientifically advanced approach to weight loss by working with your body’s natural processes. At La Chelé, these treatments are integrated into personalized wellness plans to support a safe, sustainable transformation.
If you are considering GLP-1 treatment, your La Chelé healthcare professional will work closely with you to create a personalized treatment plan that aligns with your health goals. Your provider will assess your glucose levels, BMI, and other health conditions to determine the best course of action.
At La Chelé, we offer GLP-1 agonists and other weight loss solutions designed to fit your unique needs. Our medical professionals are dedicated to comprehensive care, ensuring you achieve your weight loss goals and improve your long-term health.
Ideal candidates are individuals with a body mass index (BMI) of 27 or higher who are struggling with weight-related health concerns or have not had success with diet and exercise alone. During your consultation at La Chelé, we’ll evaluate your medical history, goals, and lifestyle to ensure this therapy is safe and appropriate for you.
Most patients begin seeing noticeable weight loss and glycemic control results within the first 4-6 weeks of starting GLP-1 treatment. Depending on individual factors like metabolism, health conditions, and adherence to diet and exercise recommendations, more significant weight loss can be observed within 2-3 months. Additionally, glucose and blood pressure improvements are often noticeable within the initial treatment period.
The results of GLP-1 treatment can be sustained long-term with continued use and adherence to lifestyle changes. Once you’ve achieved your weight loss goals, regular monitoring and support from our team can help you maintain your weight loss and manage any health conditions. Many patients continue to benefit from weight loss, lower blood sugar, and improved cardiovascular health with the right treatment plan.
Our comprehensive medical weight loss program was developed by Dr. Erin Saltzman who is a double board-certified Endocrinologist and Obesity / Weight Loss Medicine specialist.
We offer in-person consultations comprised of a complete history, physical exam, metabolic lab review and body composition analysis with an InBody scale. Our weight loss providers will work with you to develop an individualized weight loss plan (focused on diet, exercise, lifestyle and behavioral changes). If indicated, you will receive a prescription for FDA-approved weight loss medication. Follow up appointments can be in person or virtual to fit your schedule. You will also have direct access to your provider for any treatment related questions or concerns. Our goal is to help you to improve your overall health while you are losing weight.
Trusted Transformations
A Higher Standard of Beauty
More Than Just Wrinkles
Simply Flawless Experience
“There’s No Place Like La Chelé”
GLP medications work by decreasing appetite and cravings, directly targeting insulin resistance (regulating blood sugar levels) and slowing how food moves through your digestive tract (helping you to feel full for longer). However, it is crucial to understand that medications alone are not a magic solution. Successful and sustainable weight loss also requires a combination of a balanced diet, regular physical activity and addressing any underlying health conditions.
Yes, GLP medications cannot be used in individuals with:
Zepbound (Tirzepatide) is the newest FDA-approved weight loss medication. Zepbound is indicated to treat obesity, overweight and moderate to severe obstructive sleep apnea. Zepbound is a dual GLP-1 / GIP receptor agonist that is taken as a weekly subcutaneous injection.
Zepbound is a dual receptor agonist medication that triggers the activation of GIP and GLP-1 hormone receptors.
Zepbound starts working within a few days of the first dose. Most patients feel appetite suppression within the first few days and achieve notable weight loss within the first few weeks.
When used along with diet and exercise, Zepbound has been shown to decrease body weight by up to 20.2 % on average. Everyone responds differently to Zepbound and results may vary.
The cost of Zepbound depends on insurance coverage. Insurance companies require a prior-authorization to approve coverage for Zepbound. Insurance coverage qualifications include obesity (a BMI greater than / equal to 30), overweight (a BMI greater than / equal to 27 with a weight-related medical condition) and moderate to severe obstructive sleep apnea.
If you do not have coverage for Zepbound, your La Chele weight loss provider can help to find the most economic way to pay for Zepbound out-of-pocket. Eli Lilly, the company that produces Zepbound, now has a direct cash pay pharmacy with a significant discount in price.
Zepbound has many health benefits including weight loss, treatment of insulin resistance and type 2 diabetes, improvement of fatty liver, prevention of cardiovascular disease, improvement in moderate to severe obstructive sleep apnea. Zepbound may also help with memory and addiction.
Mounjaro and Zepbound are both weekly Tirzepatide (GLP-1/GIP receptor agonist) injections. However, Mounjaro is only covered by insurance for a diagnosis of Type 2 diabetes. Mounjaro can be used off-label for medical weight loss.
Yes. Under the supervision of a qualified medical provider, Zepbound is safe to use for weight loss.
You can schedule a consultation with one of our Medical Weight Loss Program Providers to see if Zepbound is right for you. If you qualify for treatment, you would receive a prescription for Zepbound to be filled at your local pharmacy or through the Lilly Direct Cash pay Pharmacy.
Wegovy (Semaglutide) is an FDA-approved weight loss medication. Wegovy is indicated to treat obesity, overweight and indicated for secondary cardiovascular protection in patients with obesity. Wegovy is a GLP-1 receptor agonist that is taken as a weekly subcutaneous injection.
Wegovy is a GLP-1 receptor agonist medication that triggers the activation of GLP-1 hormone receptors.
Wegovy starts working within a few days of the first dose. Most patients feel appetite suppression within the first few days and achieve notable weight loss within the first few weeks.
When used along with diet and exercise, Wegovy has been shown to decrease body weight by up to 13.7 on average %. Everyone responds differently to Wegovy and results may vary.
The cost of Wegovy depends on insurance coverage. Insurance companies require a prior-authorization to approve coverage for Wegovy. Insurance coverage qualifications include obesity (a BMI greater than / equal to 30), overweight (a BMI greater than / equal to 27 with a weight-related medical condition) and a history of cardiovascular disease in patients with obesity.
If you do not have coverage for Wegovy, your La Chele weight loss provider can help to find the most economic way to pay for Wegovy out-of-pocket. Novo Nordisk, the company that produces Wegovy, now has a direct cash pay pharmacy with a significant discount in price.
Wegovy has many health benefits including weight loss, treatment of insulin resistance and type 2 diabetes, improvement of fatty liver and prevention of cardiovascular disease. Wegovy may also help with memory and addiction.
Ozempic and Wegovy are both weekly Semaglutide (GLP-1 receptor agonist) injections. However, Ozempic is only covered by insurance for a diagnosis of Type 2 diabetes. Ozempic can be used off-label for medical weight loss.
Yes. Under the supervision of a qualified medical provider, Wegovy is safe to use for weight loss.
You can schedule a consultation with one of our Medical Weight Loss Program Providers to see if Wegovy is right for you. If you qualify for treatment, you would receive a prescription for Wegovy to be filled at your local pharmacy or through the NovoCare Cash Pay Pharmacy.
GLP-1 medications are administered once weekly via a small subcutaneous injection. Our providers will train you on how to self-administer the injection at home, or you may choose to receive it in-office if preferred.
Many patients begin noticing appetite suppression within the first one to two weeks. Weight loss typically becomes visible within the first month and continues to progress steadily with consistent use and proper guidance.
GLP-1 receptor agonists, which are incretin hormones, play a crucial role in regulating appetite by slowing down gastric emptying and promoting feelings of fullness after meals. This helps reduce food intake, which leads to weight loss. As appetite is suppressed, individuals tend to consume fewer calories, making it easier to stick to a healthy eating plan and achieve sustainable weight loss. The medication's impact on satiety also makes it easier for individuals to control cravings and make healthier food choices.
Yes, GLP-1 receptor agonists have shown to be effective in weight loss for individuals who do not have diabetes. In clinical trials, non-diabetic patients who were overweight or obese experienced significant weight loss with GLP-1 medications, even when used alongside diet and exercise. These medications are often prescribed for weight management in patients who struggle with obesity and have not achieved success through traditional weight loss methods alone.
GLP-1 medications are commonly administered as injectable medications. These injections are typically given once a week or daily, depending on the specific medication prescribed. There is also an option for oral semaglutide, which can be taken as a pill. The injection method allows for controlled, steady release of the medication to help manage blood glucose levels and support weight loss, while the oral version offers convenience for those who prefer a non-injectable option.
While GLP-1 receptor agonists are generally considered safe, there are some risks and side effects to be aware of. Some of the most common side effects include nausea, abdominal pain, and mild gastrointestinal issues as your body adjusts to the medication. In rare cases, GLP-1 treatments may increase the risk of medullary thyroid cancer, especially in individuals with a family history of multiple endocrine neoplasia. It's important to discuss your personal and family medical history with your healthcare provider to determine if GLP-1 is appropriate for you.
One of the most remarkable benefits of GLP-1 receptor agonists is their proven cardiovascular benefits. Studies have demonstrated that these medications can significantly reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in patients with diabetes or those at high risk of heart disease. For patients with heart failure or those at risk of heart attack, GLP-1 medications may also help lower blood pressure and improve overall cardiovascular health, potentially providing benefits for both blood sugar control and heart disease prevention. The protective effects of GLP-1 have also been noted in patients with chronic kidney disease, as it has been found to help manage kidney injury and reduce the risk of acute kidney injury.
The American Diabetes Association (ADA) highlights the effectiveness of GLP-1 in improving cardiovascular outcomes and kidney disease management. Moreover, studies show that GLP-1 agonists have a lower risk of adverse events than other diabetes medications, making them a valuable option for long-term diabetes care and weight loss.
